Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
US |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
M
|
Mastercraft Boat Holdings Inc
F:1SG
|
US |
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
US |
|
T
|
TransAlta Corp
F:TZ1
|
CA |
|
A
|
Acconeer AB
STO:ACCON
|
SE |
|
T
|
Tronox Holdings PLC
F:T5X
|
US |
|
Iss A/S
CSE:ISS
|
DK |
|
S
|
Sibanye Stillwater Ltd
JSE:SSW
|
ZA |
|
T
|
Tapestry Inc
SWB:COY
|
US |
|
F
|
FibroGen Inc
F:1FG
|
US |
|
E
|
Essent Group Ltd
XBER:EG0
|
BM |
|
C
|
Compass Inc
NYSE:COMP
|
US |
|
Chailease Holding Company Ltd
TWSE:5871
|
TW |
Wall St Price Targets
ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ALNY is 377.661 USD with a low forecast of 232.3 USD and a high forecast of 594.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALNY's stock price target?
Price Target
377.661
USD
According to Wall Street analysts, the average 1-year price target for ALNY is 377.661 USD with a low forecast of 232.3 USD and a high forecast of 594.3 USD.
What is the Revenue forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 18%.
What is the Gross Profit forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
19%
The compound annual growth rate for Gross Profit over the next 8 years is 19%.
What is the Operating Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
37%
The compound annual growth rate for Operating Income over the next 8 years is 37%.
What is the Pre-Tax Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
92%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 92%.
What is the Net Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
40%
The compound annual growth rate for Net Income over the next 8 years is 40%.
